MENU
OCT 13, 2021 10:30 AM PDT

Spatial Transcriptomic Profiling of Severe COVID-19 Patients

Sponsored by: NanoString Technologies
C.E. Credits: P.A.C.E. CE Florida CE
Speaker

Abstract

Severe SARS-CoV-2 infection often leads to development of acute respiratory distress syndrome (ARDS), with profound pulmonary patho-histological changes post-mortem. In this study, we utilized the spatial transcriptomic approach to focus on ARDS regions in SARS-CoV-2 subjects compared to other forms of virus-induced ARDS (H1N1), providing insights into regional or cell-specific differential gene regulation. We analyzed specific ARDS regions and cells of interest utilizing autopsy-derived lung tissue from patients with SARS-CoV-2 (n=3), H1N1 (n=3), and a dual infected individual (n=1). Enhanced gene signatures in alveolar epithelium, vascular tissue, and lung macrophages identified not only increased regional coagulopathy, but also increased extracellular remodeling, alternative macrophage activation, and squamous metaplasia of type II pneumocytes in SARS- CoV-2. Both the H1N1 and dual infected transcriptome demonstrated an enhanced antiviral response compared to SARS-CoV-2. Overall, these results challenge conventional wisdom and provide evidence for a more fibroproliferative ARDS phenotype in SARS-CoV-2 infection versus a more exudative inflammatory ARDS phenotype in H1N1 infection. This finding may explain the observation of COVID ARDS patients often displaying extended time requiring ventilator support. It is our hope that these pathways will improve our understanding of mechanisms leading to progressive worsening of gas exchange and increased mortality in SARS-CoV-2 related ARDS.  As a result, the potential for new therapeutic targets to alter the fibroproliferative response will present the potential to improve clinical outcomes in patients with progressive lung injury.

Learning Objectives:

1. Describe how spatial transcriptomics can be used to profile COVID-19 tissue autopsies.

2. Explain the differences seen in gene expression between SARS-CoV-2 infected lung samples and H1N1 infected lung samples.

3. Summarize the pathways involved in the fibroproliferative ARDS (Acute Respiratory Distress Syndrome) phenotype seen in SARS-CoV-2 infection.


Show Resources
You May Also Like
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
MAY 04, 2022 10:30 AM PDT
C.E. CREDITS
MAY 04, 2022 10:30 AM PDT
The coronavirus SARS-CoV-2 has led to a worldwide pandemic. Beside respiratory symptoms, infected people may develop neurologic dysfunctions such as loss of smell and taste, also seizures, a...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
MAY 19, 2022 8:00 AM PDT
MAY 19, 2022 8:00 AM PDT
Date: May 19, 2022 Time: 8:00am (PDT), 11:00pm (EDT), 5:00pm (CEST) Mass spectrometry (MS)-based proteomic technologies are increasingly applied in a clinical context for disease classific...
Loading Comments...
Show Resources